GLAXOSMITHKLINE PHARMACEUTICALS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,129 INR | +3.05% |
|
+13.76% | +12.14% |
| Apr. 25 | GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology | RE |
| Mar. 22 | GlaxoSmithKline Pharmaceuticals Limited Receives Orders from Government Authorities | CI |
Evolution of the average Target Price on GlaxoSmithKline Pharmaceuticals Limited
Price target over the last 5 years
History of analyst recommendation changes
f41bf4bf60b1e1f283b2adacd4a8fcb4.XzaaBhXxBtBIKnIEF6DKWI22Q9uoI9Q9zIquGLC_TC0.DWHpWVmTdbMiei0wRNP-IcDdCeKeVaZ8i7jBe8ToLmUldd1_IJs-_QRhNw~dc311da48ef76d07681882311bc633f4
Analysts' Consensus
Sell
Buy
Mean consensus
HOLD
Number of Analysts
4
Last Close Price
2,133
INR
Average target price
2,141
INR
Spread / Average Target
+0.40%
High Price Target
2,450
INR
Spread / Highest target
+14.88%
Low Price Target
1,895
INR
Spread / Lowest Target
-11.15%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
- Stock Market
- Equities
- GLAXO Stock
- GLAXO Stock
- Consensus GlaxoSmithKline Pharmaceuticals Limited
